Table 3.
Tumour characteristics and interventions prior to IRE.
| Author (Year) | Median Number of Tumours (Range) |
Total Number of Tumours | Median (Range) Transverse Size in cm | Inflow/ Outflow Proximity |
Interventions Prior to IRE | |||
|---|---|---|---|---|---|---|---|---|
| Chemo Therapy |
Surgery to Primary | Surgery to Metastases |
Other Treatments | |||||
| Hosein PJ (2014) [15] | 2 (1–6) | 58 | 2.7 (1.2–7.0) |
11 IVC, 9 PV, 8 HV, 3 HA | 29 (100) | 0 | 13 (45) | 2 RFA, 1 TACE, 2 SIRT |
| Scheffer HJ (2014) [9] | n/a | 54 | 2.4 (0.8–5.3) | n/a- | 8 (80) | n/a- | 10 | 30 thermal ablations. 14 resections |
| Eller A (2015) [16] | 1 (1–2) | 11 | 1.8 (0.8–2.3) | 3 RHV, 2 IVC, 4 MHV, 2 LPV, LHV, RPV | n/a | n/a | n/a | n/a- |
| Beyer L P (2017) [17] | n/a | n/a | 2.5 ± 1.1 | 5 RPV 5 LPV 4 HV 4 IVC |
n/a | n/a | n/a | n/a |
| Frühling P (2017) [18] | 1 (1–2) | 23 | 2.4 (0.8–1.4) | n/a | n/a | n/a | 16 (100%)- | n/a |
| Cornelis FH (2020) [19] | n/a | 29 | 2.1 | Portal or HV | n/a | n/a | n/a | n/a |
| Meijerink M (2021) [10] | 1 (1–4) | 76 | 2.2 (0.5–5.4) | n/a | 33 (65%) | n/a | 13 (26) | 4 Thermal ablation; 2 SBRT |
| Hitpass L (2022) [20] | n/a | 32 | 1.5 (0.4–3.9) | 13 LPV, 5 RPV, 10 MHV, 2 RHV, 2 IVC | n/a | n/a | 23 (100%) | n/a |
| Total | 283 | |||||||
IVC = inferior vena cava; PV = portal vein; LPV = Left portal vein; RPV = Right portal vein; HV = Hepatic veins; MHV = middle hepatic vein; RHV = Right hepatic vein; LHV = Left Hepatic vein; HA = hepatic artery; RFA = radiofrequency ablation; TACE = Trans-arterial chemo-embolisation; SIRT = Selective internal radiation therapy; SBRT = Stereotactic body radiation therapy.